Abstract

Background: With more than 800000 deaths and 20 million of confirmed cases worldwide, SARS-CoV 2 is one of the worst pandemic of the last decade. Questions concern the etiology of this pandemic outbreak. Was the world prepared for this pandemic? Efforts have been oriented towards treating patients who are infected presenting severe Covid-19 and preventing the spread of the virus by several means [lockdown, quarantine, social distancing, masks, antiseptic solutions]. Whereas evidence concerning the etiology treatment is still uncertain and lacking at this moment, efforts in developing vaccines for preventing another future pandemic are organized. What lessons can we get from this pandemic? Several papers have reported that children present less severe signs and symptoms than adults. There is also evidence that children at any age can be severely affected. If children are less affected than adults, why is it so? With this serious pandemic outbreak, were we or will we be prepared in the future to face a similar serious worldwide health emergency? How will we be prepared?

The Objectives of this review was to find answers to the above mentioned questions.

Methods and Materials: This review was realized between 18 March 2020 and 30 June 2020 by electronic search of scientific articles dealing with Covid-19 or SARS-CoV 2 or Coronaviridae in children in Google and Pubmed databases without date limitation. 1085 articles were identified among which 200 were retained for analysis and 48 were included for the review.

Results and Conclusions: Several reviews have been published today. This review brings updates on the

outbreak of the SARS-CoV 2 pandemic in children.

Keywords: Covid-19; SARS-Cov 2; Pandemic; Coronaviridae; Children; Review

References

1. https//www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
2. Singhal T. “A Review of Coronavirus Disease-2019”. The Indian Journal of Pediatrics4 (2020): 281-286.
3. Lai CC., et al. “Asymptomatic Carrier State, Acute Respiratory Disease and Pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-Cov 2): Facts and Myths”. Journal of Microbiology, Immunology and Infection 3 (2020): 404-412.
4. Haslak F., et al. “Childhood Rheumatic Disease and Covid-19 Pandemic: An Intriguing linkage and a New Horizon”. Balkan Medical Journal4 (2020): 184-188.
5. Guarner J. “Three emerging coronaviruses in two decades. The story of SARS, MERS and Now COVID -19”. American Journal of Clinical Pathology 153 (2020): 420-421.
6. Jiao WY., et al. “Behavioral and Emotional Disorders in Children during the COVID-19 Epidemic”. European Paediatric Association 221 (2020): 264-266.
7. Kickbusch I., et al. “COVID-19: How a virus is turning the world upside down”. BMJ 369 (2020): m1336.
8. Amanat F and Krammer F. “SARS-CoV 2 Vaccine: Status Report”. Immunity 52 (2020): 583-589.
9. Shereen MA., et al. “COVID-19 infection: Origin, Transmission and Chararcteristics of Human Coronaviruses”. Journal of Advanced Research 24 (2020): 91-98.
10. Abd El-Aziz TM and Stockand JD. “Recent Progress and Challenges in Drug Development Against COVID-19 Coronavirus (SARS-CoV 2)- An Update in the Status”. Genetics and Evolution (2020).
11. Cao Q., et al. “SARS-CoV 2 infectionin Children: Transmission dynamics and clinical characteristics”. Journal of Formosan Medical Association 119 (2020): 670-673.
12. Xu Y. “Unveiling the origin and transmission of 2019-nCoV”. Trends in Microbiology4 (2020): 239-240.
13. Toubiana J., et al. “Kawasaki-like Multisystem Inflammatory Syndrome in Children During The Covid-19 Pandemic in Paris, France: Prospective Observational Study”. BMJ 369 (2020): m2094.
14. Ludvigsson J. “Systematic Review of COVID 19 in Children shows milder cases and a better prognosis than adults”. Acta Paediatrica (2020): 1-8.
15. She J., et al. “COVID-19 epidemic: Disease Characteristics in Children”. Journal of Medical Virology (2020): 1-8.
16. Lu X., et al. “SARS-CoV 2 infection in children”. The New England Journal of Medicine 382 (2020): 1663-1665.
17. Ceccarelli M., et al. “Difference and similarities between severe acute respiratory syndrome (SARS)-Coronavirus (CoV) and SARS-CoV 2. Would a rose by another name smell as sweet?” European Review For Medical and Pharmacological Sciences 24 (2020): 2781-2783.
18. Sun D., et al. “Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan:A single Center Observational Study”. World Journal of Pediatrics (2020).
19. Canarutto D., et al. “COVID-19 infection in a paucisymptomatic infant; raisisng the index of suspicion in epidemic settings”. Pediatric Pulmonology (2020): 1-2.
20. Morand A., et al. “COVID-19 virus and children: what do we know?” Archives de Pédiatrie 27 (2020): 117-118.
21. Chen Y., et al. “Infants Born to Mothers with a new coronavirus (COVID 19)”. Frontiers in Pediatrics 8 (2020): 104.
22. Zeng L., et al. “Neonatal Early-Onset Infection with SARS-CoV 2 in 33 neonates born to mothers with COVID in Wuhan, China”. JAMA Pediatrics7 (2020): 722-725.
23. Qiu H., et al. “Clinical and Epidemiological Features of 36 Children With Coronavirus disease 2019 (COVID-19) in Zhejiang, China. An Observational Cohort Study”. Lancet Infection Disease 20 (2020): 689-696.
24. Hagmann SHF. “COVID-19 in children: More than meets the eye”. Travel Medicine and Infectious Disease (2020).
25. Yonker LM., et al. “Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS -CoV 2 infection”. Pediatric Pulmonology5 (2020): 1085-1086.
26. Su L., et al. “The different clinical characteristics of coronavirus disease cases between children and their families in China-The Character of Children with COVID-19”. Emerging Microbes and Infections 9 (2020).
27. Dong Y., et al. Pediatrics6 (2020): e20200702.
28. Nathan N., et al. “Atypical Presentation of COVID -19 in young Infants”. Lancet10235 (2020): 1481.
29. Zheng F., et al. “Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei China”. Current Medical Science2 (2020): 1-6.
30. Hong H., et al. “Clinical Characteristics of novel coronavirus disease 2019 in newborns, infants and children”. Pediatrics and Neonatology (2020).
31. Lu Q and Shi Y. “Coronavirus disease (COVID-19) and neoanate: what neonatologists need to know”. Journal of Medical Virology (2020): 1-4.
32. Riphagen S., et al. “Hyperinflammatory Shock in Children during COVID-19 Pandemic”. Lancet 10237 (2020): 1607-1608.
33. Esper F., et al. “Association between a Novel Human Coronavirus and Kawasaki Disease”. The Journal of Infectious Diseases 4 (2005): 499-502.
34. Radbd J., et al. “Use of Tocilizumab for COVID-19 infection induced cytokine release syndrome :A Cautionary Case Report”. Chest (2020).
35. Xu X., et al. “Effective treatment of severe COVID-19 patients with Tocilizumab”. Proceedings of the National Academy of Sciences of the United States of America 20 (2020): 10970-10975.
36. Zhang S., et al. “Rationale use of Tocilizumab in the treatment of novel coronavirus pneumonia”. Clinical Drug Investigation (2020).
37. Jamilloux Y., et al. “Should we stimulate or suppress immune responses in COVID -19 ? Cytokine and anti-cytokine intervention”. Autoimmunity Reviews (2020).
38. Ye Q., et al. “The pathogenesis and treatment of cytokine storm in COVID-19”. Journal of Infection (2020).
39. Jogalekar MP., et al. “Novel 2019 Coronavirus: Genome Stucture, Clinical Trials and Outstanding Questions”. Experimental Biology and Medicine (2020): 1-6.
40. Xu Y., et al. “Characteristics of Pediatric SARS-CoV 2 infection and potential evidence for persistent fecal viral shedding”. Nature Medicine 26 (2020): 502-505.
41. Gagneur A., et al. “Vertical Transmission of human coronavirus. Prospective pilot study”. Pathologie Biologie 55 (2007): 525-530.
42. Lin J., et al. “The isolation period should be longer: lesson from a child infected with SARS-CoV 2 in Chongqing, China”. Pediatric Pulmonology (2020): 1-4.
43. Zhang T., et al. “Detectable SARS-CoV 2 viral RNA in feces of three children during recovery period of COVID -19 pneumonia”. Journal of Medical Virology7 (2020): 909-914.
44. Hong X., et al. “Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?” International Journal of Infectious Disease 94 (2020): 78-80.
45. The COVID-19-APHP Group. “Assistance Publique Hôpitaux de Paris Response to The COVID-19 Pandemic”. Lancet (2020).
46. Van Lancker W and Parolin Z. “COVID-19, school closures, and child poverty: a social crisis in the making”. Lancet5 (2020): e243-e244.
47. Pathak EB., et al. “COVID-19 in children in the United States: Intensive Care Admissions, Estimated Total Infected, and Projected Numbers of Severe Pediatric Cases in 2020”. Journal of Public Health Management and Practice 4 (2020): 325-333.
48. Gambaro F., et al. “Introduction and early spread of SARS-Cov 2 in France”. bioRxiv (2020).

Citation

Citation: Claudine Kumba. “SARS CoV 2 and Coronaviridae in Children: An Updated Review". Acta Scientific Paediatrics 4.1 (2021): 34-40.

Copyright

Copyright: © 2021 Claudine Kumba. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.